Orienti I, Nguyen F, Guan P, Kolla V, Calonghi N, Farruggia G, . . . Brodeur GM. (2019). A Novel Nanomicellar Combination of Fenretinide and Lenalidomide Shows Marked Antitumor Activity in a Neuroblastoma Xenograft Model. Dove Medical Press.
Chicago Style (17th ed.) CitationOrienti I, Nguyen F, Guan P, Kolla V, Calonghi N, Farruggia G, Chorny M, and Brodeur GM. A Novel Nanomicellar Combination of Fenretinide and Lenalidomide Shows Marked Antitumor Activity in a Neuroblastoma Xenograft Model. Dove Medical Press, 2019.
MLA (9th ed.) CitationOrienti I, et al. A Novel Nanomicellar Combination of Fenretinide and Lenalidomide Shows Marked Antitumor Activity in a Neuroblastoma Xenograft Model. Dove Medical Press, 2019.
Warning: These citations may not always be 100% accurate.